CYCLONE IDAI
1.85M People affected; 400K Displaced; 603 Deaths; 1641 Injured; 1.2M People in need; 6766 Cholera cases; 43556 Malaria case
CYCLONE KENNETH
3214 Displaced; 45 Deaths; 91 Injured; 374K People in need; 225 Cholera cases; 7279 Malaria case
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
WHO clinical and policy guidelines
The classification of digital health interventions (DHIs) categorizes the different ways in which digital and mobile technologies are being used to support health system needs. Historically, the diverse communities working in digital health—including government stakeholders, technologists, clinic...ians, implementers, network operators, researchers, donors— have lacked a mutually understandable language with which to assess and articulate functionality. A shared and standardized vocabulary was recognized as necessary to identify gaps and duplication, evaluate effectiveness, and facilitate alignment across different digital health implementations. Targeted primarily at public health audiences, this Classification framework aims to promote an accessible and bridging language for health program planners to articulate functionalities of digital health implementations.
more
A 7.2-magnitude earthquake struck southwestern Haiti at 8:30am local time at a depth of around 10km. The epicentre was recorded around 12km northeast of SaintLouis-du-Sud, about 125km west of the capital Port-au-Prince.
● In the aftermath of the devastating 7.2-magnitude earthquake that hit Hai...ti on 14 August, authorities report more than 2,200 people dead, at least 344 missing, over 12,000 injured and upwards of 130,000 homes damaged or destroyed.
more
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to... understand the nature and extent of oxytocin quality issues and to provide key technical information and quality requirements for oxytocin products in dossier assessments. Furthermore, this document also presents recommendations on other regulatory actions needed to ensure that only quality-assured oxytocin products are authorized and made available to women.
more
UNAIDS and DPKO non paper | 2011
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
HIV Testing and Counselling Guidelines
Enhancing Men’s Role in HIV Prevention